GASTALDI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 1.493
AS - Asia 998
EU - Europa 854
SA - Sud America 152
Continente sconosciuto - Info sul continente non disponibili 58
AF - Africa 56
OC - Oceania 2
Totale 3.613
Nazione #
US - Stati Uniti d'America 1.424
SG - Singapore 330
CN - Cina 251
IT - Italia 214
VN - Vietnam 124
DE - Germania 120
RU - Federazione Russa 119
IE - Irlanda 113
BR - Brasile 112
HK - Hong Kong 110
FI - Finlandia 69
GB - Regno Unito 55
FR - Francia 53
BD - Bangladesh 52
IN - India 45
CA - Canada 33
ZA - Sudafrica 31
ES - Italia 24
MX - Messico 21
JP - Giappone 16
SE - Svezia 14
AR - Argentina 12
BE - Belgio 11
CO - Colombia 11
NL - Olanda 11
PL - Polonia 11
MA - Marocco 10
AT - Austria 9
IQ - Iraq 8
TR - Turchia 8
CZ - Repubblica Ceca 7
ID - Indonesia 7
MY - Malesia 6
EC - Ecuador 5
LT - Lituania 5
NP - Nepal 5
PK - Pakistan 5
SA - Arabia Saudita 5
BO - Bolivia 4
GR - Grecia 4
KE - Kenya 4
PH - Filippine 4
ET - Etiopia 3
HN - Honduras 3
IL - Israele 3
KG - Kirghizistan 3
PT - Portogallo 3
PY - Paraguay 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GT - Guatemala 2
JM - Giamaica 2
JO - Giordania 2
NI - Nicaragua 2
UA - Ucraina 2
UZ - Uzbekistan 2
AG - Antigua e Barbuda 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
GD - Grenada 1
IR - Iran 1
IS - Islanda 1
KH - Cambogia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
Totale 3.556
Città #
Singapore 197
San Jose 185
Ashburn 167
Council Bluffs 144
Dublin 113
Chandler 110
Hong Kong 107
Dallas 96
Los Angeles 68
Munich 64
Beijing 55
Ho Chi Minh City 50
Helsinki 47
New York 45
Boardman 43
Lauterbourg 35
Milan 35
Buffalo 27
Hanoi 27
Johannesburg 27
Pavia 22
Moscow 20
Redondo Beach 20
Santa Clara 20
São Paulo 20
Turku 20
Rome 17
London 15
Orem 15
Tokyo 15
Columbus 14
Montreal 14
Shanghai 14
Lawrence 13
Nanjing 13
Princeton 13
Wilmington 13
Brooklyn 12
Frankfurt am Main 12
Brussels 11
Medford 11
Stockholm 11
Chicago 10
Mexico City 10
Ann Arbor 9
Pune 9
Madrid 8
San Francisco 8
Warsaw 8
Atlanta 7
Changsha 7
Chennai 7
Florence 7
Manchester 7
Medellín 7
Nuremberg 7
Poplar 7
Bologna 6
Brno 6
Da Nang 6
Düsseldorf 6
Montemale di Cuneo 6
Baghdad 5
Cagliari 5
Dhaka 5
Guangzhou 5
Houston 5
North Kansas City 5
Paris 5
Phoenix 5
Rio de Janeiro 5
Seattle 5
Amsterdam 4
Cambridge 4
Casablanca 4
Denver 4
Falkenstein 4
Fortaleza 4
Hebei 4
Hyderabad 4
Jacksonville 4
Nanchang 4
Naples 4
New Delhi 4
Querétaro 4
Shenyang 4
The Dalles 4
Toronto 4
Athens 3
Berlin 3
Bishkek 3
Biên Hòa 3
Boston 3
Calgary 3
Castelfranco Emilia 3
City of London 3
Curitiba 3
Franca 3
Genoa 3
Hangzhou 3
Totale 2.275
Nome #
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment 163
Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma 144
Predictors of outcome in a large retrospective cohort of patients with transverse myelitis 132
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 132
COVID-19 and Guillain–Barré Syndrome: A Case Report and Review of Literature 131
Diagnostics of dysimmune peripheral neuropathies 128
Retrograde Amnesia in LGI1 and CASPR2 Limbic Encephalitis: Two Case Reports and a Systematic Literature Review 118
Diagnostics of anti-MAG antibody polyneuropathy 116
COVID-19 in patients with Myasthenia Gravis: epidemiology and disease course 115
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis 112
Antibodies to neuronal surface antigens in patients with a clinical diagnosis of neurodegenerative disorder 110
Letter to Editor 107
Lower motor neuron syndrome in a patient with HER2-positive metastatic breast cancer: A case report and review of the literature 99
Autoantibodies against neuroglial surface antigens: laboratory strategies for their detection and roles in acquired demyelinating syndromes, autoimmune encephalitis and acquired neuromyotonia 98
MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: a clinical-laboratory assessment 97
Improving laboratory diagnostics in myasthenia gravis 93
Beyond Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies: Alternative Causes of Optic Neuritis 92
Seronegative autoimmune diseases: A challenging diagnosis 91
Primary central nervous system lymphoma mimicking autoimmune encephalitis: the role of autoantibody testing 91
AQP4 autoantibodies in patients with idiopathic normal pressure hydrocephalus 90
Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis 89
Clinical Course of Neurologic Adverse Events Associated With Immune Checkpoint Inhibitors 88
Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating Disorders 86
General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis 81
HaNDL syndrome: a reversible cerebral vasoconstriction triggered by an infection? A case report and a case-based review 81
Visual System Involvement in Glial Fibrillary Acidic Protein Astrocytopathy 79
Movement disorders associated with neuronal antibodies: a data-driven approach 76
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study 74
Neurofilament-light chain quantification by Simoa and Ella in plasma from patients with dementia: a comparative study 69
Towards a standardised analysis of CSF in inflammatory neuropathies 62
COVID-19 and Guillain-Barré syndrome: A single-center prospective case series with a 1-year follow-up 61
Paraneoplastic Neurological Syndromes: Transitioning Between the Old and the New 56
Exposome, oxidative stress and inflammation in persons with multiple sclerosis: the EXPOSITION study protocol 56
Neurological complications due to copper deficiency in the context of Wilson disease treatment: a case report with long-term follow-up and review of the literature 55
Unravelling the Acute, Chronic and Steroid-Refractory Management of High-Grade Neurological Immune-Related Adverse Events: A Call to Action 47
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in a Phase II Study on GBA-Associated Parkinson’s Disease Patients 46
Insights from the EXPOSITION Study: Exposome-related microRNA Expression and Clinical Outcomes in People with multiple sclerosis 42
Clustering of Exposome and Lifestyle Data to Support Differential Expression Analysis of Circulating miRNAs in Multiple Sclerosis 41
Applying the Supporting Features for MOGAD Diagnosis to Patients With Multiple Sclerosis 31
Adoptive JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy: Experience from Two Italian Centers 28
Biomarkers Identifying Tendency to Suicide (BITS): detection of biomarkers in adolescents with suicidal ideation or suicidal behavior for early prevention or intervention. A prospective cohort study 22
Two-year OCT follow-up in multiple sclerosis patients on Ofatumumab shows retinal preservation over non-antiCD20 treatments 20
Diagnostic Value of the “Insular Knife‐Cut” Sign in Patients With Suspected Herpes Simplex Virus Encephalitis 13
Validation of the MOG-AR Score 12
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and Discrepancies 11
Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis 11
The supporting role of Visual Evoked Potentials for the diagnosis of Optic Neuritis within the 2022 ICON criteria 9
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study 6
Distinct patterns of small-fiber dysfunction in anti-myelin-associated glycoprotein-positive and negative paraproteinemic neuropathies 2
Totale 3.613
Categoria #
all - tutte 14.489
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.489


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202262 0 1 1 1 1 1 2 4 5 0 11 35
2022/2023310 26 25 5 33 26 27 0 12 133 7 14 2
2023/2024223 24 25 3 10 11 66 6 29 0 7 8 34
2024/2025732 44 40 35 20 18 52 38 16 179 47 75 168
2025/20262.014 119 88 151 258 241 105 277 87 211 131 260 86
2026/2027188 78 110 0 0 0 0 0 0 0 0 0 0
Totale 3.613